OpenVSafe by OpenVAERS
Search V-safe

763-93423-48779

1 vaccination 1 coded response 6 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
0-4
ZIP prefix
945 / CA
Registered
2022-06-24
Relationship
Child or adolescent in my care
Guardian
SAD-27499-31639
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-06-24
    Registered in v-safe
  2. 2022-06-24
    Dose 1 — Pfizer-BioNTech
  3. 2022-06-24
    Health check-in — day 0, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  4. 2022-06-25
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · Site: Itching · None
    Adult check-in
  5. 2022-06-26
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  6. 2022-06-28
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  7. 2022-07-03
    Health check-in — day 7, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  8. 2022-07-17
    Survey response — day 21, dose 1, dependent
    MedDRA: Cough, Oropharyngeal pain, Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to do your normal daily activities
    Free text: Cough, runny nose, sore throat, fever
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12022-06-24Pfizer-BioNTech No

Free text

Release 12 — day 21, dose 1, dependent

2022-07-17

Symptoms: Cough, runny nose, sore throat, fever

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDOropharyngeal pain · · ✓
SDPyrexia · · ✓
SDRhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release